Shruthi Narayan - 13 Feb 2026 Form 4 Insider Report for Penumbra Inc (PEN)

Role: President
Signature: /s/ Johanna Roberts, as attorney-in-fact for Shruthi Narayan
Issuer symbol: PEN
Transactions as of: 13 Feb 2026
Net transactions value: -$239,206
Form type: 4
Filing time: 18 Feb 2026, 20:02:25 UTC
Previous filing: 16 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Narayan Shruthi	President	ONE PENUMBRA PLACE, ALAMEDA	/s/ Johanna Roberts, as attorney-in-fact for Shruthi Narayan	18 Feb 2026	0002086163

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PEN	Common Stock	Award	$0	+2,630	+10%	$0.000000	28,947	13 Feb 2026	Direct	F1, F2
transaction	PEN	Common Stock	Tax liability	$239,206	-705	-2.4%	$339.30	28,242	15 Feb 2026	Direct	F2, F3
transaction	PEN	Common Stock	Award	$0	+2,630	+9.3%	$0.000000	30,872	17 Feb 2026	Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 13, 2026, the Reporting Person was granted 2,630 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on February 15, 2026, February 15, 2027, February 15, 2028 and February 15, 2029, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.
F2	A portion of these shares is subject to vesting.
F3	Shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person.
F4	On February 17, 2026, the Reporting Person was granted 2,630 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on February 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date.